Aysun Adan

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 9

Top Topics

Combination Therapy

Acute Myeloid Leukemia

Allogeneic Hematopoietic Stem Cell Transplantation

Tyrosine Kinase

Top Venues

Current treatment options in oncology

OncoTargets and therapy

Medical oncology (Northwood, London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Melisa Tecik, Aysun Adan
Emerging DNA Methylome Targets in FLT3-ITD-Positive Acute Myeloid Leukemia: Combination Therapy with Clinically Approved FLT3 Inhibitors. Current treatment options in oncology 25 (6) (2024)
Melisa Tecik, Aysun Adan
Emerging DNA Methylome Targets in FLT3-ITD-Positive Acute Myeloid Leukemia: Combination Therapy with Clinically Approved FLT3 Inhibitors. Current treatment options in oncology (2024)
Melisa Tecik, Aysun Adan
Emerging DNA Methylome Targets in FLT3-ITD-Positive Acute Myeloid Leukemia: Combination Therapy with Clinically Approved FLT3 Inhibitors. Current treatment options in oncology 25 (6) (2024)
Melisa Tecik, Aysun Adan
Emerging DNA Methylome Targets in FLT3-ITD-Positive Acute Myeloid Leukemia: Combination Therapy with Clinically Approved FLT3 Inhibitors. Current treatment options in oncology 25 (6) (2024)
Melisa Tecik, Aysun Adan
Emerging DNA Methylome Targets in FLT3-ITD-Positive Acute Myeloid Leukemia: Combination Therapy with Clinically Approved FLT3 Inhibitors. Current treatment options in oncology 25 (6) (2024)
Nur Şebnem Ersöz, Aysun Adan
Resveratrol triggers anti-proliferative and apoptotic effects in FLT3-ITD-positive acute myeloid leukemia cells via inhibiting ceramide catabolism enzymes. Medical oncology (Northwood, London, England) 39 (3) (2022)
Nur Şebnem Ersöz, Aysun Adan
Differential in vitro anti-leukemic activity of resveratrol combined with serine palmitoyltransferase inhibitor myriocin in FMS-like tyrosine kinase 3-internal tandem duplication (FLT3-ITD) carrying AML cells. Cytotechnology 74 (2) (2022)
Melisa Tecik, Aysun Adan
Therapeutic Targeting of FLT3 in Acute Myeloid Leukemia: Current Status and Novel Approaches. OncoTargets and therapy 15 (2022)
Osman Oğuz, Aysun Adan
Involvement of Sphingolipid Metabolism Enzymes in Resveratrol-Mediated Cytotoxicity in Philadelphia-Positive Acute Lymphoblastic Leukemia. Nutrition and cancer (2021)